The Ohio State University | Institution Partners

home / institution-partners / cancer-centers / ohio-state

Latest from The Ohio State University

FDA’s Keytruda Approval for Subset of Advanced Endometrial Cancer Provides Patients With a ‘Practice Changing’ Treatment Option

Colleen Moretti

March 29th 2022

Keytruda was well tolerated and demonstrated practice-changing responses with potential for a curative approach in a group of patients with advanced endometrial cancer, according to an expert.

Patients With Cancer Strongly Encouraged to Get COVID-19 Boosters to Protect Against Omicron Variant

Jamie Cesanek

January 18th 2022

A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777